Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

0R34

Johnson & Johnson (0R34)

Johnson & Johnson
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:0R34
DateTimeSourceHeadlineSymbolCompany
05/01/20249:17AMAlliance NewsAlliance NewsTOP NEWS: J&J proposes USD6.48 billion settlement of cancer lawsuitsLSE:0R34Johnson & Johnson
04/16/20246:54AMAlliance NewsAlliance NewsTOP NEWS: Johnson & Johnson upgrades guidance on swing to earningsLSE:0R34Johnson & Johnson
04/05/20247:02AMAlliance NewsAlliance NewsTOP NEWS: J&J swoops for Shockwave Medical in USD13.1 billion dealLSE:0R34Johnson & Johnson
03/25/20242:28PMAlliance NewsAlliance NewsIN BRIEF: J&J submits US premarket approval application for VaripulseLSE:0R34Johnson & Johnson
03/18/20247:10AMAlliance NewsAlliance NewsIN BRIEF: Johnson & Johnson receives FDA recommendation for CarvyktiLSE:0R34Johnson & Johnson
02/23/20241:32PMAlliance NewsAlliance NewsIN BRIEF: Johnson & Johnson gets EMA nod for Carvykti in myelomaLSE:0R34Johnson & Johnson
02/02/20241:22AMAlliance NewsAlliance NewsTOP NEWS: US sends drugmakers initial offers in Medicare price talksLSE:0R34Johnson & Johnson
01/23/20246:41AMAlliance NewsAlliance NewsTOP NEWS: Johnson & Johnson eyes future growth; 2023 sales riseLSE:0R34Johnson & Johnson
01/19/20244:34PMAlliance NewsAlliance NewsIN BRIEF: J&J gets US FDA approval for cancer treatment BalversaLSE:0R34Johnson & Johnson
12/05/20238:24AMAlliance NewsAlliance NewsTOP NEWS: J&J expects strong long-term growth in three key driversLSE:0R34Johnson & Johnson
10/23/20237:03AMAlliance NewsAlliance NewsJ&J report slew of positive trial results focused on various cancersLSE:0R34Johnson & Johnson
10/17/20236:46AMAlliance NewsAlliance NewsTOP NEWS: J&J raises full-year sales outlook after "solid" quarterLSE:0R34Johnson & Johnson
10/06/202311:52AMAlliance NewsAlliance NewsIN BRIEF: J&J applies for indication extension to EMA for RybrevantLSE:0R34Johnson & Johnson
10/03/202312:00PMAlliance NewsAlliance NewsDrugmakers agree to US government price talks amid pushbackLSE:0R34Johnson & Johnson
09/07/20231:50AMAlliance NewsAlliance NewsJ&J's Janssen ends Phase 3 MACiTEPH study evaluating macitentanLSE:0R34Johnson & Johnson
08/30/202312:07PMAlliance NewsAlliance NewsTOP NEWS: J&J forecasts strong growth in earnings after Kenvue splitLSE:0R34Johnson & Johnson
08/10/20234:34PMAlliance NewsAlliance NewsIN BRIEF: Johnson & Johnson's blood cancer therapy approved by FDALSE:0R34Johnson & Johnson
07/20/20237:30AMAlliance NewsAlliance NewsTOP NEWS: J&J ups full-year guidance after "robust" second quarterLSE:0R34Johnson & Johnson
05/30/202311:48AMAlliance NewsAlliance NewsJ&J seeks FDA approval for pulmonary arterial hypertension treatmentLSE:0R34Johnson & Johnson
05/09/20233:23PMAlliance NewsAlliance NewsJ&J says Tremfya data shows positive results for ulcerative colitisLSE:0R34Johnson & Johnson
05/04/20237:41AMAlliance NewsAlliance NewsIN BRIEF: J&J prices subsidiary Kenvue's NYSE initial public offeringLSE:0R34Johnson & Johnson
05/01/20232:51AMAlliance NewsAlliance NewsJohnson & Johnson reports first results from TAR-200 studyLSE:0R34Johnson & Johnson
04/18/20237:06AMAlliance NewsAlliance NewsTOP NEWS: J&J swings to first quarter loss due to litigation costsLSE:0R34Johnson & Johnson
04/05/20231:01AMAlliance NewsAlliance NewsJ&J proposes USD8.9 billion settlement of talc cancer claimsLSE:0R34Johnson & Johnson
04/04/20234:57PMAlliance NewsAlliance NewsIN BRIEF: J&J subsidiary re-files for bankruptcy amid talc claimsLSE:0R34Johnson & Johnson
03/17/20232:04PMAlliance NewsAlliance NewsIN BRIEF: Johnson & Johnson notes positive data for psoriasis drugLSE:0R34Johnson & Johnson
01/24/20237:33AMAlliance NewsAlliance NewsTOP NEWS: J&J fourth-quarter revenue falls on fewer Covid jab salesLSE:0R34Johnson & Johnson
01/05/20234:06AMAlliance NewsAlliance NewsJohnson & Johnson's consumer health unit files to go publicLSE:0R34Johnson & Johnson
12/09/202211:51AMAlliance NewsAlliance NewsIN BRIEF: Johnson & Johnson submits licence application to FDALSE:0R34Johnson & Johnson
12/01/20226:37AMAlliance NewsAlliance NewsJohnson & Johnson appoints Chief Executive Joaquin Duato as new chairLSE:0R34Johnson & Johnson
 Showing the most relevant articles for your search:LSE:0R34